This week, global biotech company Enzene Biosciences Ltd. announced it will open a state-of-the-art biopharmaceutical manufacturing plant on the Princeton West Innovation Campus in Hopewell.

Enzene Biosciences, a unit of India’s Alkem Laboratories, has unveiled plans to open a $50 million manufacturing facility near Princeton, New Jersey. The CDMO expects to hire as many as 300 new ...

Enzene Biosciences, a Pune-based biopharmaceutical and contract development and manufacturing organization (CDMO). (Image/Enzene Biosciences) Enzene Biosciences, a Pune-based biopharmaceutical and ...

(IE) Biopharmaceutical company, Enzene Biosciences, a subsidiary of Alkem Labs, is planning to launch its seventh biosimilar, Ranibizumab in the country soon. Ranibizumab is a biosimilar of ...

Enzene or its parent Alkem which is commercialising the drug didn't announce the price, but said it would be competitively priced. The company said that globally also, COVID-19 related quarantines ...

Biotech company Enzene Biosciences Ltd (Enzene), a subsidiary of Alkem Laboratories, has raised $50 million from Alkem Laboratories, Eight Roads Ventures, and F-Prime Capital.

Momentum is building in Mercer County. On the heels of an announcement earlier this month that Enzene Biosciences will open a state-of-the-art biopharmaceutical manufacturing site at the Princeton ...

Enzene Biosciences has rolled out its version of bevacizumab, its sixth biosimilar in over two years. Bevacizumab, used in treating metastatic colorectal cancer, was originally sold by Roche ...

New Delhi: Pune-based Enzene Biosciences followed by the launch of Bevacizumab to treat metastatic colorectal cancer, as brought in Ranibizumab, a biosimilar to the breakthrough medication ...

Widely recognized as a pioneer in continuous manufacturing, Pune-based contract development & manufacturing organization (CDMO), Enzene Biosciences recently announced the launch of its first ...